生物传感器检测药物发现中的体受体相互作用的类型及其作用
Garima Gupta1, Kanupriya Jha1, Sarika Chaudhary1
1Department of Biotechnology, School of Engineering and Applied Sciences, Bennett University, Greater Noida, India.
Assay and drug development technologies
|June 7, 2023
概括
本综述探讨了药物向相互作用的生物传感器,重点介绍了无标签系统和先进的3D模型. 这些创新提高了药物发现效率,降低了成本,为更好的疗法铺平了道路.
科学领域:
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
- 生物传感器技术技术
背景情况:
- 体受体相互作用 (LRIs) 对细胞过程至关重要,并已被用于敏感的生物传感器发展.
- 药物向相互作用,一个关键的LRI,对于理解生物过程和开发新疗法至关重要.
- 无标签生物传感器系统通过避免与标签相关的问题,节省时间和精力,在传统方法上提供优势.
研究的目的:
- 提供基于药物标相互作用的生物传感器测试的深入分析.
- 评估各种生物传感器类型在成本,灵敏度和选择性方面的优点和局限性.
- 讨论这些生物传感器技术在药物发现和开发中的工业应用.
主要方法:
- 对生物传感器测定药物向相互作用的现有文献的审查.
- 分析无标签生物传感方法及其益处.
- 在药物查中对先进的培养模型 (3D,有机体,芯片上的器官) 的评估.
- 讨论多重复和纳米技术对生物传感器有效性的影响.
主要成果:
- 无标签生物传感器规避了诸如形状变化和场外标签等问题,简化了测试开发.
- 与传统的二维模型相比,三维 (3D) 培养模型提供了更具生理相关性的体外方法.
- 多重复合和纳米技术的进步正在提高生物传感器的有效性,从而导致小型化和护理点应用.
结论:
- 基于药物标相互作用的生物传感器是药物发现和开发的重要工具.
- 无标签和先进的3D培养技术在提高药物查效率和预测性方面取得了重大进展.
- 生物传感器技术的持续创新,包括纳米技术,有望在诊断和治疗方面取得进一步的进步.
相关概念视频
02:40Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
00:49Ligand Binding and Linkage
3.1K
3.1K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:28Structure-Activity Relationships and Drug Design
800
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
800
02:18The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
01:29The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K